%0 Journal Article
%T The syndrome of inappropriate antidiuretic hormone associated with nasal and paranasal malignant tumors.
%A Dang S
%A Zhang S
%A Zhao J
%A Li X
%A Li W
%J Eur Arch Otorhinolaryngol
%V 281
%N 3
%D 2024 Mar 2
%M 38163817
%F 3.236
%R 10.1007/s00405-023-08347-5
%X <B>OBJECTIVE: </B>To investigate the clinical characteristics of the syndrome of inappropriate antidiuretic hormone (SIADH) associated with nasal and paranasal malignant tumors.<BR><B>METHODS: </B>Patients with locally advanced or recurrence/metastatic malignant tumors of the nasal and paranasal sinuses were included. The SIADH was diagnosed according to the diagnostic criteria. The clinical characteristics of SIADH patients were retrospectively analyzed.<BR><B>RESULTS: </B>Six patients (6/188, 3.2%) met the diagnostic criteria of SIADH, including four olfactory neuroblastoma (4/26, 15.4%), one neuroendocrine carcinoma (1/9, 11.1%), and one squamous cell carcinoma (1/63, 1.6%). Five patients (83.3%) had severe hyponatremia; however, the hyponatremia could be improved by fluid restriction or tolvaptan. Three patients' SIADH were recovered during the chemotherapy and the other three were recovered after the surgery.<BR><B>CONCLUSIONS: </B>The incidence of SIADH associated with nasal and paranasal malignant tumors is relatively more common in olfactory neuroblastoma and neuroendocrine carcinoma. The hyponatremia caused by SIADH may be corrected by fluid restriction or tolvaptan, and the SIADH may be recovered through anti-tumor therapy.